ONCT - Oncternal Therapeutics GAAP EPS of -$0.20 in-line revenue of $0.2M beats by $0.06M May, 04 2023 04:52 PM Oncternal Therapeutics Inc. 2023-05-04 16:52:52 ET Oncternal Therapeutics press release ( NASDAQ: ONCT ): Q1 GAAP EPS of -$0.20 in-line. Revenue of $0.2M (-71.4% Y/Y) beats by $0.06M . For further details see: Oncternal Therapeutics GAAP EPS of -$0.20 in-line, revenue of $0.2M beats by $0.06M